524640 Stock Overview Manufactures and trades in chemical products in India and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Archit Organosys Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Archit Organosys Historical stock prices Current Share Price ₹47.73 52 Week High ₹62.00 52 Week Low ₹35.10 Beta 0.12 1 Month Change 3.54% 3 Month Change 5.48% 1 Year Change -16.69% 3 Year Change 8.97% 5 Year Change 374.45% Change since IPO 23.02%
Recent News & Updates
Chairman recently bought ₹684k worth of stock Dec 26
New major risk - Financial position Nov 25
Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer Oct 01
Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary Sep 14
Archit Organosys Limited, Annual General Meeting, Sep 09, 2024 Aug 20
Archit Organosys Limited, Annual General Meeting, Sep 09, 2024 Aug 19 See more updates
Chairman recently bought ₹684k worth of stock Dec 26
New major risk - Financial position Nov 25
Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer Oct 01
Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary Sep 14
Archit Organosys Limited, Annual General Meeting, Sep 09, 2024 Aug 20
Archit Organosys Limited, Annual General Meeting, Sep 09, 2024 Aug 19 Archit Organosys Limited to Report Q2, 2025 Results on Nov 14, 2024
First quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.77 in 1Q 2024) Aug 13
Archit Organosys Limited to Report Q1, 2025 Results on Aug 08, 2024 Aug 02
Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer Jun 29
Whole Time Director recently bought ₹796k worth of stock Jun 25
Investor sentiment improves as stock rises 25% Jun 14
Full year 2024 earnings released: EPS: ₹1.60 (vs ₹5.53 in FY 2023) Jun 04
New major risk - Market cap size May 31
Archit Organosys Limited to Report Q4, 2024 Results on May 30, 2024 May 24
Investor sentiment improves as stock rises 18% Apr 01
Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million. Mar 29
Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million. Mar 28
Now 20% undervalued after recent price drop Mar 22
New major risk - Market cap size Mar 13
Third quarter 2024 earnings released: ₹0.22 loss per share (vs ₹1.09 profit in 3Q 2023) Feb 15
New minor risk - Profit margin trend Nov 11
Archit Organosys Limited Declares Dividend Sep 01
New minor risk - Earnings quality Aug 17
Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022) Aug 15 Archit Organosys Limited to Report Q3, 2024 Results on Feb 14, 2024
Upcoming dividend of ₹0.50 per share at 1.0% yield Aug 11
Archit Organosys Limited Proposes Declare Aug 10
Archit Organosys Limited to Report Q1, 2024 Results on Aug 14, 2023 Aug 06
Investor sentiment improves as stock rises 16% Aug 03
Upcoming dividend of ₹0.50 per share at 0.9% yield Aug 01
Archit Organosys Limited, Annual General Meeting, Aug 22, 2023 Jul 25
Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022) May 15
Archit Organosys Limited Recommends a Final Dividend for the Financial Year Ended March 31, 2023 May 13
Chairman & Whole Time Director recently bought ₹507k worth of stock Mar 08
Chairman & Whole Time Director recently bought ₹1.3m worth of stock Feb 02
Investor sentiment deteriorated over the past week Jan 20
Third quarter 2023 earnings released: EPS: ₹1.09 (vs ₹0.99 in 3Q 2022) Jan 14
Archit Organosys Limited to Report Q3, 2023 Results on Jan 13, 2023 Jan 05
Investor sentiment improved over the past week Dec 07
Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022) Nov 16
Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022) Nov 13
Archit Organosys Limited to Report Q2, 2023 Results on Nov 11, 2022 Nov 03
Archit Organosys Limited Announces Chief Financial Officer Changes Oct 11
Investor sentiment improved over the past week Sep 27
Archit Organosys Limited Approves Dividend Sep 09
Investor sentiment improved over the past week Aug 18
Archit Organosys Limited, Annual General Meeting, Sep 08, 2022 Aug 10
First quarter 2023 earnings released: EPS: ₹2.01 (vs ₹1.42 in 1Q 2022) Jul 26
Archit Organosys Limited to Report Q1, 2023 Results on Jul 25, 2022 Jul 19
Archit Organosys Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022 May 14
Investor sentiment improved over the past week Apr 04
Archit Organosys Limited Announces Appointment of Vijay A. Boliya as Company Secretary and Compliance Officer, Effective March 1, 2022 Mar 01
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 15
Archit Organosys Limited Announces Resignation of Anchal Bansal as Company Secretary and Compliance Officer Feb 09
Second quarter 2022 earnings released: EPS ₹0.68 (vs ₹0.70 in 2Q 2021) Nov 04
First quarter 2022 earnings released: EPS ₹1.42 (vs ₹0.55 in 1Q 2021) Aug 09
Independent Director Rajendraprasad Shah has left the company Jul 20
Investor sentiment improved over the past week Jul 05
Full year 2021 earnings released: EPS ₹3.33 (vs ₹0.53 loss in FY 2020) Jun 18
Investor sentiment improved over the past week Jun 08
Investor sentiment improved over the past week May 22
Investor sentiment improved over the past week Apr 20
Third quarter 2021 earnings released: EPS ₹1.02 (vs ₹0.37 loss in 3Q 2020) Feb 17
Archit Organosys Limited to Report Q3, 2021 Results on Feb 13, 2021 Feb 06
Investor sentiment improved over the past week Feb 06
New 90-day high: ₹25.00 Feb 06
New 90-day high: ₹24.55 Jan 05
Investor sentiment deteriorated over the past week Dec 14
New 90-day high: ₹23.80 Dec 07
Archit Organosys Limited to Report First Half, 2021 Results on Nov 09, 2020 Oct 29
New 90-day high: ₹14.60 Oct 15
Archit Organosys Limited announced that it expects to receive INR 13.75 million in funding Oct 01
First quarter earnings released Sep 18
Full year earnings released - ₹0.53 loss per share Sep 11
New 90-day high - ₹10.56 Sep 03
Full year earnings released - ₹0.53 loss per share Aug 04 Shareholder Returns 524640 IN Chemicals IN Market 7D -0.9% 1.2% 1.8% 1Y -16.7% 2.5% 18.0%
See full shareholder returns
Return vs Market: 524640 underperformed the Indian Market which returned 18% over the past year.
Price Volatility Is 524640's price volatile compared to industry and market? 524640 volatility 524640 Average Weekly Movement 4.7% Chemicals Industry Average Movement 5.9% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 524640 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524640's weekly volatility (5%) has been stable over the past year.
About the Company Archit Organosys Limited manufactures and trades in chemical products in India and internationally. The company offers monochloroacetic acid and sodium monochloroacetate that are used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives, etc. It also provides organic chemicals, pigments, and specialty derivatives, as well as adhesives and sealants under the AOL brand. The company was formerly known as Shri Chlochem Limited and changed its name to Archit Organosys Limited in May 2012.
Show more Archit Organosys Limited Fundamentals Summary How do Archit Organosys's earnings and revenue compare to its market cap? 524640 fundamental statistics Market cap ₹979.45m Earnings (TTM ) ₹32.93m Revenue (TTM ) ₹1.12b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 524640 income statement (TTM ) Revenue ₹1.12b Cost of Revenue ₹795.81m Gross Profit ₹327.66m Other Expenses ₹294.73m Earnings ₹32.93m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
Earnings per share (EPS) 1.60 Gross Margin 29.17% Net Profit Margin 2.93% Debt/Equity Ratio 45.6%
How did 524640 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/03 20:45 End of Day Share Price 2025/01/03 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Archit Organosys Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
